SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Abbott India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500488

INE358A01014

2246.6776471

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ABBOTINDIA

38.25

59361.03

EPS(TTM)

Face Value()

Div & Yield %

730.36

1.7

Back

Basilic Fly Studio consolidated net profit rises 139.90% in the September 2025 quarter

Nov 12,2025

Net profit of Basilic Fly Studio rose 139.90% to Rs 14.13 crore in the quarter ended September 2025 as against Rs 5.89 crore during the previous quarter ended September 2024. Sales rose 67.80% to Rs 94.49 crore in the quarter ended September 2025 as against Rs 56.31 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	94.49	56.31	68
OPM %	21.54	15.52	-
PBDT	19.64	9.29	111
PBT	17.85	7.49	138
NP	14.13	5.89	140

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)